Evgeny N. Imyanitov

6.4k total citations · 1 hit paper
278 papers, 4.1k citations indexed

About

Evgeny N. Imyanitov is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Evgeny N. Imyanitov has authored 278 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Molecular Biology, 116 papers in Oncology and 93 papers in Genetics. Recurrent topics in Evgeny N. Imyanitov's work include BRCA gene mutations in cancer (69 papers), Cancer Genomics and Diagnostics (64 papers) and Lung Cancer Treatments and Mutations (43 papers). Evgeny N. Imyanitov is often cited by papers focused on BRCA gene mutations in cancer (69 papers), Cancer Genomics and Diagnostics (64 papers) and Lung Cancer Treatments and Mutations (43 papers). Evgeny N. Imyanitov collaborates with scholars based in Russia, United States and Finland. Evgeny N. Imyanitov's co-authors include Aglaya G. Iyevleva, Anna P. Sokolenko, E. Levchenko, Evgeny N. Suspitsin, Ekatherina Sh. Kuligina, Alexandr V. Togo, Svetlana N. Aleksakhina, K.P. Hanson, Alexandr O. Ivantsov and Natalia V. Mitiushkina and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Evgeny N. Imyanitov

239 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives

2020 339 citations Evgeny N. Imyanitov, Aglaya G. Iyevleva et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evgeny N. Imyanitov Russia	31	2.2k	1.4k	1.2k	1.1k	864	278	4.1k
Dieter Niederacher Germany	38	2.4k 1.1×	1.6k 1.1×	1.4k 1.2×	854 0.8×	408 0.5×	143	4.2k
Hitoshi Zembutsu Japan	33	1.5k 0.7×	1.5k 1.0×	834 0.7×	830 0.7×	549 0.6×	76	3.8k
Constance T. Albarracin United States	43	1.8k 0.8×	1.7k 1.2×	2.1k 1.7×	894 0.8×	851 1.0×	122	5.2k
Ingunn M. Stefansson Norway	36	2.2k 1.0×	1.5k 1.0×	1.3k 1.1×	470 0.4×	552 0.6×	73	4.4k
Susan M. Henshall Australia	45	2.3k 1.1×	1.9k 1.4×	1.2k 1.0×	667 0.6×	1.6k 1.9×	83	5.0k
Dean B. Evans Switzerland	39	2.1k 1.0×	2.7k 1.9×	2.0k 1.6×	2.1k 1.9×	994 1.2×	107	5.6k
Nina N. Nupponen Finland	35	2.2k 1.0×	999 0.7×	1.1k 0.9×	610 0.6×	1.4k 1.6×	64	4.5k
Kirsten M. Timms United States	27	2.2k 1.0×	2.6k 1.8×	1.2k 1.0×	1.5k 1.3×	535 0.6×	96	4.6k
Heli Nevanlinna Finland	43	3.1k 1.4×	1.7k 1.2×	1.5k 1.2×	2.3k 2.0×	353 0.4×	124	5.2k
Rolf I. Skotheim Norway	41	3.4k 1.6×	1.1k 0.7×	1.5k 1.2×	504 0.5×	1.1k 1.3×	108	5.3k

Countries citing papers authored by Evgeny N. Imyanitov

Since Specialization

Citations

This map shows the geographic impact of Evgeny N. Imyanitov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evgeny N. Imyanitov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evgeny N. Imyanitov more than expected).

Fields of papers citing papers by Evgeny N. Imyanitov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evgeny N. Imyanitov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evgeny N. Imyanitov. The network helps show where Evgeny N. Imyanitov may publish in the future.

Co-authorship network of co-authors of Evgeny N. Imyanitov

This figure shows the co-authorship network connecting the top 25 collaborators of Evgeny N. Imyanitov. A scholar is included among the top collaborators of Evgeny N. Imyanitov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evgeny N. Imyanitov. Evgeny N. Imyanitov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yanus, Grigoriy A., Ekatherina Sh. Kuligina, & Evgeny N. Imyanitov. (2024). Hereditary Renal Cancer Syndromes. SHILAP Revista de lepidopterología. 12(1). 12–12. 4 indexed citations

Kuligina, Ekatherina Sh., D. Yu. Trofimov, Aniruddh Kashyap, et al.. (2024). HLA gene polymorphism is a modifier of age-related breast cancer penetrance in carriers of BRCA1 pathogenic alleles. Breast Cancer Research and Treatment. 209(2). 341–354.

Проценко, Светлана, et al.. (2023). Immune checkpoint inhibitors for the treatment of solid tumors in HIV-infected patients: is it worth the risk?. SHILAP Revista de lepidopterología. 22(1). 141–150. 1 indexed citations

Yanus, Grigoriy A., Aglaya G. Iyevleva, Evgeny N. Suspitsin, et al.. (2023). Hereditary predisposition to kidney cancer: cancer syndromes, multisystemic disorders, and nephropathies. SHILAP Revista de lepidopterología. 14(2). 5–20.

Sokolenko, Anna P., Elena V. Preobrazhenskaya, Cláudia Marchetti, et al.. (2023). Origin of Residual Tumor Masses in BRCA1/2-Driven Ovarian Carcinomas Treated by Neoadjuvant Chemotherapy: Selection of Preexisting BRCA1/2-Proficient Tumor Cells but Not the Gain of Second ORF-Restoring Mutation. Pathobiology. 91(2). 108–113. 2 indexed citations

Preobrazhenskaya, Elena V., et al.. (2023). ALK, ROS1, RET and NTRK1–3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers. International Journal of Molecular Sciences. 24(17). 13610–13610. 11 indexed citations

Preobrazhenskaya, Elena V., et al.. (2023). Spectrum of kinase gene rearrangements in a large series of paediatric inflammatory myofibroblastic tumours. Histopathology. 83(1). 109–115. 5 indexed citations

Mitiushkina, Natalia V., Grigoriy A. Yanus, Svetlana N. Aleksakhina, et al.. (2023). KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas. International Journal of Molecular Sciences. 24(5). 4868–4868. 14 indexed citations

Moiseyenko, Fedor V., Ekatherina Sh. Kuligina, Maksim Kholmatov, et al.. (2022). Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer. International Journal of Clinical Oncology. 27(5). 850–862. 6 indexed citations

10.

Ворохобина, Н. В., et al.. (2021). Clinical and laboratory features of hereditary pheochromocytoma and paraganglioma. Problems of Endocrinology. 68(1). 8–17. 6 indexed citations

11.

Matsko, Dmitry E., et al.. (2021). EMBRYONAL TUMORS OF THE CENTRAL NERVOUS SYSTEM IN ADULTS: A REPORT OF THREE CASES. REVIEW OF THE LITERATURE. SHILAP Revista de lepidopterología. 20(1). 105–114. 1 indexed citations

12.

Imyanitov, Evgeny N.. (2021). Cytotoxic and targeted therapy for BRCA1/2-driven cancers. Hereditary Cancer in Clinical Practice. 19(1). 36–36. 13 indexed citations

13.

Orlov, Sergey, Aglaya G. Iyevleva, Е. А. Филиппова, et al.. (2021). Efficacy of lorlatinib in lung carcinomas carrying distinct ALK translocation variants: The results of a single-center study. Translational Oncology. 14(8). 101121–101121. 7 indexed citations

14.

Sokolenko, Anna P. & Evgeny N. Imyanitov. (2017). Molecular Tests for the Choice of Cancer Therapy. Current Pharmaceutical Design. 23(32). 4794–4806. 7 indexed citations

15.

Белоусова, Е. Д., et al.. (2016). The first results of tuberous sclerosis registry. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2 indexed citations

16.

Imyanitov, Evgeny N., et al.. (2016). BRCA1GENE EXPRESSION IN ENDOCRINE TUMORS OF THE GASTROINTESTINAL TRACT. SHILAP Revista de lepidopterología. 1 indexed citations

17.

Проценко, Светлана, et al.. (2014). Modern options in personalized therapy of metastatic cutaneous melanoma. SHILAP Revista de lepidopterología. 1 indexed citations

18.

Yanus, Grigoriy A., Alexandr O. Ivantsov, Ekatherina Sh. Kuligina, et al.. (2013). Pattern of clinically relevant mutations in consecutive series of Russian colorectal cancer patients. Medical Oncology. 30(3). 686–686. 43 indexed citations

19.

Russnes, Hege G., Ekatherina Sh. Kuligina, Evgeny N. Suspitsin, et al.. (2011). Paired distribution of molecular subtypes in bilateral breast carcinomas. Cancer Genetics. 204(2). 96–102. 9 indexed citations

20.

Knyazev, Piotr G., et al.. (1992). Amplification of ERBB-2 (HER-2/NEU) Oncogene in Different Neoplasms of Patients from USSR. Oncology. 49(2). 162–165. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact